Literature DB >> 26672410

Prediction of Angiographic Extent of Coronary Artery Disease on the Basis of Clinical Risk Scores in Patients of Unstable Angina.

Gaurav Khandelwal1, Anoop Jain2, Monika Rathore3.   

Abstract

BACKGROUND: The correlation of clinical risk predictors and clinical risk scores: Thrombolysis in Myocardial Infarction (TIMI), Platelet Glycoprotein IIb-IIIa in Unstable Angina, Receptor Suppression Using Integrilin Therapy (PURSUIT) and Global Registry of Acute Coronary Events (GRACE) scores in Unstable Angina with angiographic extent of Coronary Artery Disease (CAD) is not known. AIM: To know the correlation of clinical risk scores with angiographic extent of coronary artery disease.
MATERIALS AND METHODS: This was a hospital based single centre, cross-sectional, observational, descriptive study conducted at a tertiary care teaching institute. One hundred and sixty patients with acute unstable angina were evaluated for presence of 9 clinical predictors and their 3 risk scores were calculated. All patients underwent coronary angiography. Correlation with Modified Gensini score and percentage stenosis in culprit artery was done. STATISTICAL ANALYSIS: Data were summarized in the form of Mean, Standard Deviation and Proportions. Multiple linear regressions, Student's t-test and Pearson's coefficient 'r' were also used.
RESULTS: Use of aspirin, age >= 65 years & presence of Congestive Heart Failure (CHF) were stronger predictors of Modified Gensini score. Presence of elevated enzymes and age >65 years were more significant predictors of percentage stenosis of culprit artery. GRACE score had better correlation with Modified Gensini score, PURSUIT score had more correlation with percentage stenosis in culprit artery.
CONCLUSION: Use of Aspirin, age >= 65 years, presence of CHF and presence of elevated enzymes are stronger predictors of extent of CAD. Hence we recommend that these factors be given more importance. GRACE and PURSUIT risk scores had more correlation with angiographic extent of CAD.

Entities:  

Keywords:  Angiographic severity; GRACE score; Modified gensini score; PURSUIT score; TIMI score

Year:  2015        PMID: 26672410      PMCID: PMC4668449          DOI: 10.7860/JCDR/2015/15069.6778

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  [Correlation of TIMI risk score with angiographic extent and severity of coronary artery disease in non-ST-elevation acute coronary syndromes].

Authors:  H Ben Salem; S Ouali; S Hammas; I Bougmiza; R Gribaa; K Ghannem; E Neffati; F Remadi; E Boughzela
Journal:  Ann Cardiol Angeiol (Paris)       Date:  2011-01-12

3.  Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris.

Authors:  Zafer Isilak; Ejder Kardesoglu; Mustafa Aparci; Omer Uz; Murat Yalcin; Omer Yiginer; Bekir Yilmaz Cingozbay; Mehmet Uzun
Journal:  Kardiol Pol       Date:  2012       Impact factor: 3.108

4.  Early versus delayed invasive intervention in acute coronary syndromes.

Authors:  Shamir R Mehta; Christopher B Granger; William E Boden; Philippe Gabriel Steg; Jean-Pierre Bassand; David P Faxon; Rizwan Afzal; Susan Chrolavicius; Sanjit S Jolly; Petr Widimsky; Alvaro Avezum; Hans-Jurgen Rupprecht; Jun Zhu; Jacques Col; Madhu K Natarajan; Craig Horsman; Keith A A Fox; Salim Yusuf
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

5.  TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.

Authors:  Pedro de Araújo Gonçalves; Jorge Ferreira; Carlos Aguiar; Ricardo Seabra-Gomes
Journal:  Eur Heart J       Date:  2005-03-11       Impact factor: 29.983

6.  Correlation of angiographic morphology and clinical presentation in unstable angina.

Authors:  G Dangas; R Mehran; S Wallenstein; N A Courcoutsakis; V Kakarala; J Hollywood; J A Ambrose
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

7.  Correlation of TIMI risk score with angiographic severity and extent of coronary artery disease in patients with non-ST-elevation acute coronary syndromes.

Authors:  Santiago Garcia; Mariana Canoniero; Arley Peter; Eduardo de Marchena; Alexandre Ferreira
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

8.  A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors.

Authors:  D R Sullivan; T H Marwick; S B Freedman
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

9.  Assessment of the prognostic value of coronary angiography in patients with non-ST segment elevation myocardial infarction.

Authors:  Paweł Maciejewski; Paweł Lewandowski; Wojciech Wąsek; Andrzej Budaj
Journal:  Kardiol Pol       Date:  2013       Impact factor: 3.108

10.  Percutaneous coronary intervention in the elderly.

Authors:  Simon J Walsh; Kathy McAuley; Paul W Johnston
Journal:  Ulster Med J       Date:  2007-01
View more
  2 in total

1.  Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study.

Authors:  Manal S Fawzy; Eman A Toraih; Nagwa M Aly; Abeer Fakhr-Eldeen; Dahlia I Badran; Mohammad H Hussein
Journal:  BMC Cardiovasc Disord       Date:  2017-01-13       Impact factor: 2.298

2.  Association of Angio-LncRNAs MIAT rs1061540/MALAT1 rs3200401 Molecular Variants with Gensini Score in Coronary Artery Disease Patients Undergoing Angiography.

Authors:  Mohamed Y Elwazir; Mohammad H Hussein; Eman A Toraih; Essam Al Ageeli; Safya E Esmaeel; Manal S Fawzy; Salwa Faisal
Journal:  Biomolecules       Date:  2022-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.